Flexion Therapeutics, Inc. (NASDAQ:FLXN) Q3 2018 Earnings Conference Call Transcript

Nov 07, 2018 • 04:30 pm ET

Previous

Flexion Therapeutics, Inc. (NASDAQ:FLXN) Q3 2018 Earnings Conference Call Transcript

Share
Close

Loading Event

Loading Transcript

Presentation
Operator
Operator

Good afternoon, ladies and gentlemen, and welcome to the Flexion Therapeutics Third Quarter Financial Results Conference Call. My name is Daniel, and I will be your coordinator today. At this time, all participants are in listen-only mode. We will be facilitating a question-and-answer session at the end of today's call. (Operator Instructions) I'll now turn the call over to the company.

Executive
Scott Young

Thanks, Daniel. Good afternoon. This is Scott Young, VP for Corporate Communications and IR. Both the earnings release we issued this afternoon and an archive of this conference call can be found on the company's website at flexiontherapeutics.com. Today's call will be led by Flexion's CEO, Dr. Michael Clayman; and he is joined by Dan Deardorf, SVP of Commercial Operations; and David Arkowitz, Flexion's CFO. (Forward-Looking Cautionary Statements) I will now turn the call over to Flexion's CEO, Mike Clayman.